Ttbio Corp. (TPEX:6493)
28.25
+1.85 (7.01%)
At close: Feb 11, 2026
Ttbio Revenue
Ttbio had revenue of 212.92M TWD in the half year ending June 30, 2025, with 28.06% growth. This brings the company's revenue in the last twelve months to 392.72M, up 38.21% year-over-year. In the year 2024, Ttbio had annual revenue of 312.12M, down -1.88%.
Revenue (ttm)
392.72M
Revenue Growth
+38.21%
P/S Ratio
2.16
Revenue / Employee
3.33M
Employees
118
Market Cap
848.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 312.12M | -5.97M | -1.88% |
| Dec 31, 2023 | 318.09M | -100.79M | -24.06% |
| Dec 31, 2022 | 418.88M | 113.37M | 37.11% |
| Dec 31, 2021 | 305.52M | 126.56M | 70.72% |
| Dec 31, 2020 | 178.96M | -87.62M | -32.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.20B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |
| Crystalvue Medical | 905.73M |
| Concord Medical | 905.31M |
| Maxigen Biotech | 792.49M |